Medical Oncology

Prof. Dr. Aziz Yazar

Doctor and researcher Acıbadem Altunizade Hastanesi İstanbul
Lung NeoplasmsCarcinoma, Non-Small-Cell LungAdenocarcinomaUterine NeoplasmsHelicobacter InfectionsColonic Diseases, Functional
Open institution page
Suggest a correction

Is this your profile? Claim it and verify your details.

Claim profile

Person ↔ Disease

Which diseases does this doctor work on?

From source
  • Lung Neoplasms 4 publications
    Source: OpenAlex / PubMed MeSHView publications
  • Carcinoma, Non-Small-Cell Lung 3 publications
  • Adenocarcinoma 2 publications
  • Uterine Neoplasms 2 publications
  • Helicobacter Infections 2 publications
  • Colonic Diseases, Functional 2 publications

Person ↔ Disease

Which topics does this doctor work on?

From source

Medical areas of interest stated by the doctor on the institution profile. Source: acibadem.com.tr.

  • Akciğer, Akciğer Zarı Kanserleri (Mezotelyoma) ve Diğer Torasik Kanserler
  • Meme Kanseri
  • Mide Kanseri
  • Pankreas Kanseri
  • Prostat Kanseri
  • Yumurtalık (Over) Kanseri
  • Beyin Tümörleri
  • Mesane Kanseri
  • Endometrial Kanser
  • Baş Boyun Kanserleri
  • Karaciğer Kanseri
  • Böbrek Kanseri
  • Kolorektal Kanserler (Kolon ve Rektum Kanseri)
  • Malign Melanom ve Diğer Deri Tümörleri
  • Akciğer Kanseri
  • Kolon (Kalın Bağırsak) Kanseri

CV

Education and experience

From source

Experience

  • 2007Acıbadem Sağlık Grubuacibadem.com.tr
  • 2005 - 2007American Hastanesiacibadem.com.tr
  • 2002 - 2005İstanbul Üniversitesi Onkoloji Enstitüsü / Medikal Onkolojiacibadem.com.tr
  • 1999 - 2002Mersin Üniversitesi Tıp Fakültesiacibadem.com.tr
  • 1993 - 1998İstanbul Üniversitesi İstanbul Tıp Fakültesiacibadem.com.tr

Education

  • 2010Acıbadem Üniversitesi Tıp Fakültesi, Digeracibadem.com.tr
  • 2005İstanbul Üniversitesi Onkoloji Enstitüsü, Tıbbi Onkoloji, Üst Uzmanlıkacibadem.com.tr
  • 2004İstanbul Üniversitesi Onkoloji Enstitüsü / Doçent, Digeracibadem.com.tr
  • 1997İstanbul Üniversitesi İstanbul Tıp Fakültesi, İç Hastalıkları, Uzmanlıkacibadem.com.tr
  • 1993Hacettepe Üniversitesi Tıp Fakültesi, Tıp, Üniversiteacibadem.com.tr

Trust

Where does this information come from?

The source is stated next to each piece of information. If you see something wrong, you can suggest a correction.

  • SpecialtyMedical Oncologyacibadem.com.trFrom source
  • InstitutionAcıbadem Altunizade Hastanesiacibadem.com.trFrom source
  • Area of workLung NeoplasmsExtracted from 4 publications · Model version —From source
  • Publications42 publicationsOpenAlexFrom source
  • Last synchronised4 November 2026 21:00https://www.acibadem.com.tr/doktor/aziz-yazar/acibadem.com.tr

Scientific work

Publications on Lung Neoplasms

42 publications

  1. Real-World Efficacy and Safety of Frontline Enfortumab Vedotin Plus Pembrolizumab in Metastatic Urothelial Carcinoma: A Multicenter Study and Review of the Literature

    Clinical Genitourinary Cancer, 2026

    DOI 10.1016/j.clgc.2026.102594 PMID 42349378 Source: OpenAlex

  2. 42P Concordance of CanAssist breast with Oncotype Dx and MammaPrint in patients with early stage hormone receptor positive breast cancer

    ESMO Open, 2025

    DOI 10.1016/j.esmoop.2025.104596 Open-access full textSource: OpenAlex

  3. Cognitive Impairment in Caregivers of Cancer Patients: A Cross-sectional Study

    Acta haematologica oncologica Turcica., 2024

    DOI 10.4274/ahot.galenos.2024.89896 1 citation (OpenAlex) Open-access full textSource: OpenAlex

  4. The Prevalence of Obesity in Adult Population in a City on the Mediterranean Coast of Turkey

    DOAJ (DOAJ: Directory of Open Access Journals), 2022

    Source: OpenAlex

  5. Prognostic Significance of Tumor Tissue NeuGcGM3 Ganglioside Expression in Patients Receiving Racotumomab Immunotherapy

    Journal of Oncology, 2020

    DOI 10.1155/2020/1360431 PMID 32670370 5 citations (Europe PMC) Open-access full textSource: OpenAlex

  6. Prognostic significance of tumour tissue NeuGcGM3 ganglioside expression and predictive value of circulating tumour cell count monitoring in patients receiving racotumomab immunotherapy

    Annals of Oncology, 2019

    DOI 10.1093/annonc/mdz253.091 Source: OpenAlex

  7. Comparison of SP142 (Ventana) and SP263 (Ventana) assays to test PD-L1 expression in metastatic cancer patients to be treated with immune checkpoint inhibitors.

    Journal of Clinical Oncology, 2018

    DOI 10.1200/jco.2018.36.15_suppl.e24306 Source: OpenAlex

  8. Cytolytic tests with hyperimmune patient sera is a good prognostic tool in racotumomab immunotherapy in advanced non-small cell lung cancer

    Advances in Modern Oncology Research, 2017

    DOI 10.18282/amor.v3.i5.212 Source: OpenAlex

  9. Evre IV küçük hücreli dışı akciğer kanserinde serum vasküler endotelyal büyüme faktörü ve Bcl-2 düzeyleri ve aralarındaki ilişki

    DergiPark (Istanbul University), 2014

    Source: OpenAlex

  10. Clinical and pathologic characteristics of patients with breast cancer and a second non-breast primary tumor.

    Journal of Clinical Oncology, 2013

    DOI 10.1200/jco.2013.31.15_suppl.e11539 Source: OpenAlex

View all 42 publications